| Synthesis, reactivity, and biological activity of gold (I) complexes modified with thiourea-functionalized tyrosine kinase inhibitors M Yang, AJ Pickard, X Qiao, MJ Gueble, CS Day, GL Kucera, U Bierbach Inorganic chemistry 54 (7), 3316-3324, 2015 | 34 | 2015 |
| Design and cellular studies of a carbon nanotube-based delivery system for a hybrid platinum-acridine anticancer agent CD Fahrenholtz, S Ding, BW Bernish, ML Wright, Y Zheng, M Yang, X Yao, ... Journal of inorganic biochemistry 165, 170-180, 2016 | 23 | 2016 |
| Human Serum Albumin-Delivered [Au(PEt3)]+ Is a Potent Inhibitor of T Cell Proliferation TC Dean, M Yang, M Liu, JM Grayson, AW DeMartino, CS Day, J Lee, ... ACS Medicinal Chemistry Letters 8 (5), 572-576, 2017 | 16 | 2017 |
| Metal‐Containing Pharmacophores in Molecularly Targeted Anticancer Therapies and Diagnostics M Yang, U Bierbach European Journal of Inorganic Chemistry 2017 (12), 1561-1572, 2017 | 15 | 2017 |
| Platination of cysteine by an epidermal growth factor receptor kinase-targeted hybrid agent M Yang, H Wu, J Chu, LA Gabriel, Y Kim, KS Anderson, CM Furdui, ... Chemical communications 54 (54), 7479-7482, 2018 | 10 | 2018 |
| Au-ACRAMTU-PEt3 alters redox balance to inhibit T cell proliferation and function PK Langston, M Yang, U Bierbach, D Parsonage, LB Poole, MJ Price, ... The Journal of Immunology 195 (5), 1984-1994, 2015 | 6 | 2015 |
| Toll-like receptor 7 and 8 imidazoquinoline-based agonist/antagonist pairs M Yang, PG Larson, L Brown, JR Schultz, TA Kucaba, TS Griffith, ... Bioorganic & Medicinal Chemistry Letters 59, 128548, 2022 | 4 | 2022 |
| An electrophilic fragment screening for the development of small molecules targeting caspase-2 ME Cuellar, M Yang, S Karavadhi, YQ Zhang, H Zhu, H Sun, M Shen, ... European Journal of Medicinal Chemistry 259, 115632, 2023 | 2 | 2023 |
| Proteasomal stimulation by MK886 and its derivatives can rescue tau-induced neurite pathology EE Liao, M Yang, N Nathan Kochen, N Vunnam, AR Braun, DM Ferguson, ... Molecular neurobiology 60 (10), 6133-6144, 2023 | 2 | 2023 |
| Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling N Vunnam, M Yang, CH Lo, C Paulson, WD Fiers, E Huber, MJ Been, ... ACS bio & med Chem Au 3 (3), 270-282, 2023 | 2 | 2023 |
| Chemoselective Bioconjugation of Amyloidogenic Protein Antigens to PEGylated Microspheres Enables Detection of α-Synuclein Autoantibodies in Human Plasma P Ge, M Yang, JL Bouchard, N Dzamko, SJG Lewis, GM Halliday, ... Bioconjugate Chemistry 33 (2), 301-310, 2022 | | 2022 |
| Functionalized tyrosine kinase inhibitors modified with precious metal electrophiles and methods associated therewith U Bierbach, M Yang, AJ Pickard US Patent 10,047,057, 2018 | | 2018 |
| Design, synthesis and characterization of multifunctional platinum-[benz] acridine agents X Yao, M Wright, M Yang, J Lee, C Furdui, U Bierbach ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | | 2017 |
| Acid-labile linker design for targeted delivery and release of platinum-acridine anticancer agents H Wang, M Yang, U Bierbach ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | | 2017 |
| Targeting ErbB tyrosine kinases with platinum-functionalized small molecule inhibitors M Yang, H Wu, T West, C Furdui, G Kucera, U Bierbach ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | | 2017 |
| Gold-phosphines and gold-phosphine-modified human serum albumin as potent inhibitors of T-cell proliferation T Dean, M Yang, M Liu, P Langston, J Lee, C Furdui, J Grayson, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | | 2017 |
| Synthetic and Mechanistic Studies of Precious Metal-Modified Tyrosine Kinase Inhibitors M Yang Wake Forest University, 2017 | | 2017 |
| Targeting cancer-related kinases with metal-functionalized inhibitors M Yang, AJ Pickard, MV Wright, GL Kucera, U Bierbach ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 247, 2014 | | 2014 |
Ulrich BierbachWake Forest UniversityVerified email at wfu.edu
